Kei Sakamoto
@keisakamoto.bsky.social
Professor Univ. of Copenhagen, Vice Director Novo Nordisk Foundation Center for Basic Metabolic Research, Metabolic Signaling, glucose metabolism, AMPK
Happy to have contributed to this very interesting work ked/driven by Raid Nisr, Alison McNeilly and Graham Rena (University of Dundee). doi.org/10.1111/apha...
May 23, 2025 at 5:33 AM
Happy to have contributed to this very interesting work ked/driven by Raid Nisr, Alison McNeilly and Graham Rena (University of Dundee). doi.org/10.1111/apha...
Th most-cited research papers of all time. A 1951 publication by US biochemist Oliver Lowry in the Journal of Biological Chemistry describing an assay to determine the amount of protein in a solution has been cited more than 350,000 times.
April 21, 2025 at 11:00 AM
Th most-cited research papers of all time. A 1951 publication by US biochemist Oliver Lowry in the Journal of Biological Chemistry describing an assay to determine the amount of protein in a solution has been cited more than 350,000 times.
Eli Lilly announced positive results from a large clinical trial of its once-daily pill orforglipron in people with type 2 diabetes, while Pfizer announced last week it was halting development of its candidate after signs of liver injury in a trial participant.
April 21, 2025 at 7:45 AM
Eli Lilly announced positive results from a large clinical trial of its once-daily pill orforglipron in people with type 2 diabetes, while Pfizer announced last week it was halting development of its candidate after signs of liver injury in a trial participant.
Pleased to share our new preprint describing mechanistic insights and cellular selectivity of the AMPK inhibitor.
March 6, 2025 at 12:40 PM
Pleased to share our new preprint describing mechanistic insights and cellular selectivity of the AMPK inhibitor.